ANTI-ADHESION DEVICE PREMARKET REQUIREMENTS RECONSIDERED BY FDA AFTER PANEL VOTES AGAINST APPROVAL OF GENZYME'S SEPRACOAT; AGENCY MAY HOLD PUBLIC FORUM
Keep up with the top medtech business and regulatory news.
Medtech Insight brings you interviews and analysis, on the go.